Sponsor Pipeline

Akebia Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
3
Recruiting
1
Phase 3
2
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-05 NCT06419205
A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in…		 Recruitment opened
Active Trials by Phase
Phase 3
1
Phase 2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06901505 To Evaluate the Efficacy of Three Times Weekly (TIW) Vadadustat Compared to Standard of… Anemia of Chronic Kidney Disease Active, Not Recruiting
Phase 2
NCT06419205 A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in… IgA Nephropathy Recruiting
NCT07268638 A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS) Focal Segmental Glomerulosclerosis Recruiting
Phase 1
NCT07429006 SAD and MAD Study of AKB-9090 in Healthy Adult Participants Healthy Volunteers Recruiting
Disease Areas
Lupus (SLE) (1) Chronic Kidney Disease (1)
Get alerts when Akebia Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free